Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)

Clinical trial NCT02040220 · COMPLETED

Trial details

NCT number: NCT02040220
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Retinal Vein Occlusion

Start date: 2014-01-24
Primary completion: 2018-06-01
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.